We are developing a monoclonal antibody and cellular immunotherapy platform to support the State of Indiana in research and therapeutics development.
We will engineer novel monoclonal antibodies and CAR-T, CAR-M and CAR-NK cells. We will perform validation of cellular products and collaborate with the Cell & Gene Therapy Manufacturing core facility to develop products for clinical trials.
